(Q81159022)
Statements
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia (English)
Haralampos J Milionis
Eleni T Bairaktari
Alexandros D Tselepis